Company

28.01.2020

Once again this year, we are launching new OTC medicines

Once again this year, we are launching new OTC medicines

This month, our brand new OTC medicines - Magnefar® B6 Forte and Magnefar® B6 Bio arrived at pharmacies in Poland. This is yet another success of Biofarm, responding to the needs of patients who suffer from fatigue, cramps and other symptoms of magnesium deficiency.

Magnefar® B6 Forte and Magnefar® B6 Bio contain well-absorbed magnesium citrate2 and vitamin B6, which positively affects the bioavailability of magnesium ions. Our products are available in two variants:

Magnefar® B6 Bio

Magnefar® B6 Forte

60 mg of magnesium citrate

100 mg of magnesium citrate

6.06 mg of vitamin B6

10.10 mg of vitamin B6

pack of 50 tablets

pack of 60 tablets


Magnefar® B6 Forte is one of the OTC medicines available on the Polish market with the highest dose of magnesium citrate.

Magnefar® B6 Forte and Magnefar® B6 Bio are medicinal products recommended for the treatment of magnesium deficiency which may be indicated by the following symptoms:

  • nervousness, irritability, mood swings, mild anxiety, anxiety, temporary tiredness, drowsiness, mild sleep disturbance;
  • anxiety symptoms such as gastrointestinal cramps or palpitations (without heart problems);
  • muscle cramps, tingling, eyelid twitching.

Products should be used after excluding the causes of symptoms other than magnesium deficiency and when it is not possible to achieve improvement or increase in magnesium supply by following a healthy diet.1

1SmPC Magnefar B6 Bio, 10/2019.
2Gortat M. Biodostępność magnezu i jego rola w prawidłowym funkcjonowaniu organizmu. Nauki Przyrodnicze nr 2(2)2013 s. 27-36.

.

OTC medicine

Magnefar® B6 Forte

Read more
OTC medicine

Magnefar® B6 Bio

Read more

Summary of drug characteristics: Magnefar® B6 Bio, Magnefar® BForte

Magnefar® B6 Bio: 1 film-coated tablet contains 60 mg of magnesium ions in the form of magnesium citrate and 6.06 mg of pyridoxine hydrochloride.

Magnefar® B6 Forte: 1 film-coated tablet contains 100 mg of magnesium ions in the form of magnesium citrate and 10.10 mg of pyridoxine hydrochloride.

Indications: Magnefar® B6 Bio and Magnefar® B6 Forte medicinal products are recommended for the treatment of magnesium deficiency. The occurrence of the following symptoms may indicate magnesium deficiency: nervousness, irritability, mood swings, mild anxiety, anxiety, temporary tiredness, drowsiness, mild sleep disturbance; symptoms of anxiety such as gastrointestinal cramps or palpitations (without heart problems); muscle cramps, tingling, eyelid twitching. Products should be used after excluding the causes of symptoms other than magnesium deficiency and when it is not possible to achieve or increase magnesium supply by following a healthy diet. In the absence of improvement after a month of using Magnefar® B6 Bio or Magnefa®r B6 Forte, continuation of treatment is not recommended.

Contraindications: Hypersensitivity to the active substances or to any of the excipients. Magnefar® B6 Bio, Magnefar® B6 Forte should not be used in hypermagnesaemia, acute renal failure (creatinine clearance <30ml / min), significant hypotension, atrioventricular block and myasthenia gravis.

Marketing authorization holder: Biofarm® Sp. z o.o., ul. Wałbrzyska 13, 60-198 Poznań, Poland

Before use, please read the information leaflet, which contains indications, contraindications, data on adverse effects and dosage, as well as information on the use of the medicinal product, or consult a doctor or pharmacist, as any drug used contrary to its purpose can be dangerous to your life and health.

Share: